CAS 475085-57-5

2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]acetic acid

Description:

2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]acetic acid, with the CAS number 475085-57-5, is a synthetic organic compound characterized by its complex molecular structure, which includes a pyrazine ring and a butoxyacetic acid moiety. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity due to its amine and carboxylic acid functional groups. The presence of the diphenyl and pyrazinyl groups suggests that it may have interesting interactions with biological targets, making it a candidate for pharmaceutical research. Its molecular weight and specific stereochemistry can influence its pharmacokinetic and pharmacodynamic properties. Additionally, the compound may undergo various chemical reactions, including esterification and amide formation, which can be relevant in medicinal chemistry for developing derivatives with enhanced efficacy or reduced toxicity. Overall, this compound represents a class of molecules that could be explored for therapeutic applications, particularly in areas related to cancer or neurological disorders, although specific biological activities would require empirical investigation.

Formula: C₂₅H₂₉N₃O₃

InChI: InChI=1S/C25H29N3O3/c1-19(2)28(15-9-10-16-31-18-23(29)30)22-17-26-24(20-11-5-3-6-12-20)25(27-22)21-13-7-4-8-14-21/h3-8,11-14,17,19H,9-10,15-16,18H2,1-2H3,(H,29,30)

InChI key: InChIKey=OJQMKCBWYCWFPU-UHFFFAOYSA-N

SMILES: N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3

Synonyms:

• Acetic acid, [4-[(5,6-diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-
• MRE 269
• Acetic acid, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-
• 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]acetic acid
• ACT 333679
• ACT-333679; MRE269; MRE 269; ACT333679; ACT 333679
• Selexipag impurity 6/Selexipag Acid/2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid
• {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic acid
• Selexipag internate 2
• 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid
• [4-[(5,6-DIPHENYLPYRAZINYL)(1-METHYLETHYL)AMINO]BUTOXY]-ACETIC ACID
• MRE-269 (ACT-333679)
• MRE-269 Selexipag Active Metabolite
• {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid
• 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid
• MRE-269 S
• Selexipag metabolite ACT-333679
• Slapag metabolite ACT-333679

[4-[(5,6-diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-acetic acid

CAS: 475085-57-5

Formula: C₂₅H₂₉N₃O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 419.5161

Ref: IN-DA00DAAQ

MRE-269

CAS: 475085-57-5

MRE-269

Purity: ≥98%

Molecular weight: 419.52g/mol

Ref: 54-BUP06039

Selexipag Metabolite (MRE-269, ACT-333679)

CAS: 475085-57-5

Formula: C₂₅H₂₉N₃O₃

Color and Shape: Pale Yellow Solid

Molecular weight: 419.53

Ref: 4Z-S-101003

2-(4-((5,6-Diphenylpyrazin-2-Yl)(Isopropyl)Amino)Butoxy)Acetic Acid

CAS: 475085-57-5

2-(4-((5,6-Diphenylpyrazin-2-Yl)(Isopropyl)Amino)Butoxy)Acetic Acid

Purity: 98%

Molecular weight: 419.52g/mol

Ref: 54-OR1027786

MRE-269

CAS: 475085-57-5

MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug, used for the treatment of pulmonary arterial hypertension.

Formula: C₂₅H₂₉N₃O₃

Purity: 98.25%

Color and Shape: Solid

Molecular weight: 419.52

Ref: TM-T3S2007

Selexipag Acid

CAS: 475085-57-5

Formula: C₂₅H₂₉N₃O₃

Molecular weight: 419.52

Ref: ST-EA-CP-S20003

MRE-269

Controlled Product

CAS: 475085-57-5

Formula: C₂₅H₂₉N₃O₃

Color and Shape: Neat

Molecular weight: 419.52

Ref: TR-M750110

MRE-269-d10

Controlled Product

CAS: 475085-57-5

Formula: C₂₅D₁₀H₁₉N₃O₃

Color and Shape: Neat

Molecular weight: 429.578

Ref: TR-M750113